Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations

2021 | journal article; research paper. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Sarcoidosis Following Hematopoietic Stem Cell Transplantation: Clinical Characteristics and HLA Associations​
Wurm-Kuczera, R. I.; Buentzel, J.; Koenig, J. F. L.; Legler, T.; Valk, J.-J.; Hasenkamp, J. & Jung, W. et al.​ (2021) 
Frontiers in Immunology12.​ DOI: https://doi.org/10.3389/fimmu.2021.746996 

Documents & Media

License

Published Version

Attribution 4.0 CC BY 4.0

Details

Authors
Wurm-Kuczera, Rebecca Isabel; Buentzel, Judith; Koenig, Julia Felicitas Leni; Legler, Tobias; Valk, Jan-Jakob; Hasenkamp, Justin; Jung, Wolfram; Rademacher, Jan-Gerd; Korsten, Peter; Wulf, Gerald Georg
Abstract
Purpose Extrinsic factors and genetic predisposition contribute to the etiology of sarcoidosis, converging in a phenotype of altered immune response associated with multisystemic inflammatory granulomatous tissue infiltration. Immunological reconstitution after hematopoietic stem cell transplantation (HSCT) may represent a unique window for the pathogenesis of the disease. We describe the incidence, clinicopathological features, and HLA associations of sarcoidosis after HSCT in a single-center cohort of patients, together with data from previously published cases. Methods We retrospectively analyzed clinical characteristics and HLA haplotypes from allogeneic (allo) or autologous (auto) HSCT patients from January 2001 through May 2021 at the University Medicine Goettingen (UMG), and data from previously published cases. Results A total number of 19 patients was identified. These included 4 patients from our center (3 allo HSCT and 1 auto HSCT) and 15 patients from the literature review. Thirteen patients had received an allo HSCT, and six patients had received an auto HSCT. Sarcoidosis occurred after a median interval of 20 (after allo HSCT) and 7 (after auto HSCT) months, respectively. The predominant HLA allele associated with sarcoidosis was HLA DRB1 03:01. Sarcoidosis involved the respiratory tract in 15 patients (three unknown, one without pulmonary involvement), and it was associated with graft-versus-host disease in 7 of 13 patients receiving allo HSCT. None of the donors or patients had a history of sarcoidosis before transplantation. Disease manifestations resolved with standard glucocorticoid treatment without long-term sequelae. Conclusion Sarcoidosis may occur at low frequency during reconstitution of the immune system after HSCT. HLA allele associations reflect the associations observed in the general population, particularly with DRB1 03:01. Further insights into the interplay between Tcell reconstitution and the development of sarcoidosis could also provide novel approaches to an improved understanding of the pathogenesis in sarcoidosis.
Issue Date
2021
Journal
Frontiers in Immunology 
Organization
Klinik für Nephrologie und Rheumatologie 
eISSN
1664-3224
Sponsor
Open-Access-Finanzierung durch die Universitätsmedizin Göttingen 2021

Reference

Citations


Social Media